Multidisciplinary blended learning to build a breast cancer specialist career: survey on the perspective of the first 2 cohorts of the ESO-ULM Certificate of Competence in Breast cancer (CCB).
Journal
BMC medical education
ISSN: 1472-6920
Titre abrégé: BMC Med Educ
Pays: England
ID NLM: 101088679
Informations de publication
Date de publication:
05 May 2022
05 May 2022
Historique:
received:
03
07
2021
accepted:
25
04
2022
entrez:
5
5
2022
pubmed:
6
5
2022
medline:
10
5
2022
Statut:
epublish
Résumé
Breast Cancer (BC) specialists need to acquire comprehensive knowledge, covering their own specialty and principles of related disciplines. Blended learning, the integration of online and face-to-face learning, is becoming more and more important in academic education and has added value during pandemics which limit face-to-face learning and residential training. In this context, the ESO-ULM Certificate of Competence in Breast Cancer (CCB) provides postgraduate multidisciplinary education and delivers an academic postgraduate title. The aim of this work is to investigate the degree of satisfaction of 42 participants to the first two editions of the programme and to assess if attending the programme entailed any professional gain. An ad-hoc questionnaire was developed exploring 4 areas: participants' characteristics, administrative aspects, CCB Program syllabus and design, professional impact. The program was attractive for specialists of different disciplines from all over the world: > 90% of responders appreciated the curriculum set up and the quality of the teaching. Despite 64% of responders changed their clinical practice, only 33% could implement institutional changes. One third of the participants activated a collaboration with other colleagues and 64% used the CCB as a trigger to take part in other educational activities. Only 12% of the participants had the opportunity, after CCB, to visit other BC Units or to be involved in international research projects. More than half of the attendees profited from attending CCB in terms of promotions (16.7%), change of working institution (9.5%) or development of a more structured educational program at their home institutions (28.6%). Results provide interesting and stimulating considerations on the expectations and needs of training physicians and on what modern educational tools and formats can achieve. This paper can provide useful information to navigate through what the post-graduate training market is currently offering to develop a specific curriculum in modern multidisciplinary BC care but might not be applicable to other fields of multidisciplinary oncology.
Sections du résumé
BACKGROUND
BACKGROUND
Breast Cancer (BC) specialists need to acquire comprehensive knowledge, covering their own specialty and principles of related disciplines. Blended learning, the integration of online and face-to-face learning, is becoming more and more important in academic education and has added value during pandemics which limit face-to-face learning and residential training. In this context, the ESO-ULM Certificate of Competence in Breast Cancer (CCB) provides postgraduate multidisciplinary education and delivers an academic postgraduate title. The aim of this work is to investigate the degree of satisfaction of 42 participants to the first two editions of the programme and to assess if attending the programme entailed any professional gain.
METHODS
METHODS
An ad-hoc questionnaire was developed exploring 4 areas: participants' characteristics, administrative aspects, CCB Program syllabus and design, professional impact.
RESULTS
RESULTS
The program was attractive for specialists of different disciplines from all over the world: > 90% of responders appreciated the curriculum set up and the quality of the teaching. Despite 64% of responders changed their clinical practice, only 33% could implement institutional changes. One third of the participants activated a collaboration with other colleagues and 64% used the CCB as a trigger to take part in other educational activities. Only 12% of the participants had the opportunity, after CCB, to visit other BC Units or to be involved in international research projects. More than half of the attendees profited from attending CCB in terms of promotions (16.7%), change of working institution (9.5%) or development of a more structured educational program at their home institutions (28.6%).
CONCLUSIONS
CONCLUSIONS
Results provide interesting and stimulating considerations on the expectations and needs of training physicians and on what modern educational tools and formats can achieve. This paper can provide useful information to navigate through what the post-graduate training market is currently offering to develop a specific curriculum in modern multidisciplinary BC care but might not be applicable to other fields of multidisciplinary oncology.
Identifiants
pubmed: 35513883
doi: 10.1186/s12909-022-03414-7
pii: 10.1186/s12909-022-03414-7
pmc: PMC9070614
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
344Informations de copyright
© 2022. The Author(s).
Références
Eur J Cancer. 2015 Oct;51(15):2191-2205
pubmed: 26421822
Educ Inf Technol (Dordr). 2021;26(5):6143-6161
pubmed: 34121908
Eur J Surg Oncol. 2020 Aug;46(8):1393-1395
pubmed: 32248999
Eur J Surg Oncol. 2020 Apr;46(4 Pt B):717-736
pubmed: 32075718
Asian Pac J Cancer Prev. 2019 Jul 01;20(7):2015-2020
pubmed: 31350959
J Cancer Educ. 2020 Oct 21;:
pubmed: 33089455
BMC Med Educ. 2019 Jul 30;19(1):289
pubmed: 31362735
J Med Internet Res. 2020 Aug 10;22(8):e16504
pubmed: 32773378
BMJ. 2012 Apr 26;344:e2718
pubmed: 22539013
J Oncol Pract. 2018 Dec;14(12):e815-e822
pubmed: 30537454
J Oncol Pract. 2016 Feb;12(2):177; e215-23
pubmed: 26286099
Cardiol Young. 2021 May;31(5):734-743
pubmed: 33320078
Clin Med (Lond). 2007 Jan-Feb;7(1):37-42
pubmed: 17348573
Breast. 2020 Jun;51:65-84
pubmed: 32217457
Postgrad Med J. 2007 Apr;83(978):212-6
pubmed: 17403945
Med Teach. 2012;34(4):e216-21
pubmed: 22455712
Eur J Surg Oncol. 2020 Apr;46(4 Pt B):715-716
pubmed: 32088005
BMC Res Notes. 2017 Jan 13;10(1):39
pubmed: 28086959
Eur J Surg Oncol. 2019 Apr;45(4):567-572
pubmed: 30638809